UNSPSC 51372125: Hydromorphone hydrochloride

This classification denotes an opiate with the molecular formula C17H19NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L960UP2KRW, chemically known as morphinone, dihydro-, hydrochloride but more generally known as hydromorphone hydrochloride, which bears US NIH Compound Identifier 3648. European Medicines Agency schedules Hydromorphone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02573MIG.

Most nations, for tariff and trade purposes, schedule hydromorphone hydrochloride under HS 29391100 and SITC 54141. As of Q4 2014, HYDROMORPHONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Hydromorphone hydrochloride bears US NLM identifiers UMLS ID C0700533 and NCI Concept Code C436. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2C(=O)CC[C@H]3[C@H]1C5)O.CL.

UNSPSC 51372125 Hydromorphone hydrochloride is a Commodity code that represents pharmaceutical opioid products used in pain management and palliative care. State and local procurement activity under this code shows limited recent volume, with solicitations focused on controlled-substance acquisition for public health and community health initiatives rather than routine medical supply chains. The issuing bodies purchasing under this code include county health departments and public health agencies responsible for emergency response, harm reduction, and community health programs. Procurement typically involves competitive bidding processes with strict compliance requirements including drug-free workplace certification, E-Verify employment eligibility verification, and adherence to federal regulations governing controlled substances.

Seminole County, Florida posted the primary recent opportunity under this code—an IFB (Invitation for Bid) for naloxone and safe drug deactivation systems with a response deadline of July 26, 2023. While the solicitation number IFB60459723LAS was posted June 30, 2026, the actual bid deadline recorded in the source is July 26, 2023, indicating this opportunity is no longer active. The procurement called for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors were required to include all shipping and delivery costs in their proposals, submit bids electronically through the county's e-Procurement Portal, and meet federal compliance requirements including potential FEMA-related audits. The contract offered a two-year initial term with a one-year renewal option and included a three-month probationary period. Recent activity under this code appears sparse, with the Seminole County opportunity representing the only documented state or local solicitation in the provided dataset.